Aspire Biopharma regains Nasdaq minimum bid price compliance
Source: SeekingAlpha
2026-02-10 08:15:18 ET
More on Aspire Biopharma Holdings, Inc.
- Seeking Alpha’s Quant Rating on Aspire Biopharma Holdings, Inc.
- Financial information for Aspire Biopharma Holdings, Inc.
Read the full article on Seeking Alpha
For further details see:
Aspire Biopharma regains Nasdaq minimum bid price compliance
Aspire Biopharma Holdings Inc.
NASDAQ: ASBP
ASBP Trading
2.44% G/L:
$1.225 Last:
90,988 Volume:
$1.24 Open:
ASBP Latest News
March 10, 2026 08:30:00 am
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack
March 03, 2026 08:00:00 am
Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief
February 25, 2026 08:30:00 am
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship
February 20, 2026 08:00:00 am
Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements
